Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 98.10 | 98.10 | 0.00 |
Other | 1.97 | 1.97 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.00 | 20.27 |
Price to Book | 4.92 | 4.55 |
Price to Sales | 4.41 | 2.48 |
Price to Cash Flow | 16.97 | 17.14 |
Dividend Yield | 0.97 | 1.12 |
5 Years Earnings Growth | 6.52 | 10.27 |
Number of long holdings: 196
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 13.46 | 163.79 | +1.85% | |
Amgen | US0311621009 | 7.11 | 311.34 | +11.84% | |
Krystal Biotech | US5011471027 | 6.44 | 161.10 | +0.54% | |
Regeneron Pharma | US75886F1075 | 4.22 | 957.00 | +2.07% | |
Vertex | US92532F1003 | 3.16 | 401.08 | +0.23% | |
Gilead | US3755581036 | 2.19 | 64.78 | -0.84% | |
Alnylam | US02043Q1076 | 2.01 | 152.33 | +1.34% | |
Ascendis Pharma AS | US04351P1012 | 1.98 | 137.20 | -2.76% | |
Apellis Pharma | US03753U1060 | 1.71 | 47.46 | -0.06% | |
Arcellx Inc | - | 1.70 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 534.04B | 10.55 | 11.48 | 12.95 | ||
Fidelity Contrafund | 128.94B | 17.98 | 12.69 | 14.65 | ||
Fidelity Contrafund K | 128.94B | 17.99 | 12.77 | 14.75 | ||
Fidelity Total Market Index Instl b | 90.96B | 10.05 | 9.66 | 12.27 | ||
Strategic Advisers Core | 62.96B | 11.57 | 11.66 | 12.74 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review